Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Optimisation of Follicular Recruitment in IVM Cycles
- Status
- COMPLETED
- Phase
- PHASE3
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sugammadex and Decreased Time to Extubation
- Status
- COMPLETED
- Phase
- PHASE4
SHOWME-PAD (Peripheral Artery Disease)
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)
- Status
- COMPLETED
- Phase
- PHASE3
Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)
- Status
- COMPLETED
- Phase
- PHASE1
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
- Status
- TERMINATED
- Phase
- PHASE2
Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)
- Status
- COMPLETED
- Phase
- PHASE3
Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
- Status
- COMPLETED
- Phase
- PHASE2
Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetics Distribution of Raltegravir by PET/MR
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Influence of Deep Versus Moderate Neuromuscular Blockade During General Anesthesia on 30-day Readmission Rates
- Status
- COMPLETED
- Phase
- N/A
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2